Plasminogen Replacement Therapy for Congenital Plasminogen Deficiency

January 4, 2018

At Prometic Life Sciences we are committed to addressing unmet medical needs in rare diseases such as Congenital Plasminogen Deficiency (PLGD). Congenital PLGD is an inherited disorder passed on from generation to generation in which a person is born with two mutated genes, one from each parent. This is commonly referred to as an autosomal recessive pattern. It is caused by changes in the gene that gives instructions to make plasminogen (PLG).

For more information on PLGD, visit http://plasminogen.com/ 

Previous Video
Virtual Tour of Prometic Life Science's Manufacturing Process
Virtual Tour of Prometic Life Science's Manufacturing Process

Next Video
Joe Parker, MD: PBI-4050 Demonstrates Promising Efficacy Results for IPF Treatment
Joe Parker, MD: PBI-4050 Demonstrates Promising Efficacy Results for IPF Treatment

Prometic Life Science's senior director details the promising efficacy PBI-4050 alone or in combination wit...